-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 1, Horizon Biotech announced two important executive appointments.
From now on, Mr.
Long Jiang (John Long) will serve as Horizon Bio’s chief financial officer and will join the company’s board of directors.
He will be fully responsible for the company’s capital market business (including (Dual listing), investor relations and company financial management, etc.
, directly report to the company's founder and chairman Dr.
Zang Jingwu
.
Before joining Tianjing Bio, Mr.
Long Jiang served as the chief financial officer or senior vice president of finance in biomedical companies such as WuXi AppTec Group, WuXi MingMa, Zhenhe Technology, and Si Microbiology, and led a number of important positions.
Strategic transaction and business cooperation
.
Mr.
At the same time, with immediate effect, Mr.
Zhu Jielun will be transferred to the company's chief strategy officer
.
Mr.
Note: The original text has been deleted